Hosted on MSN

GeneSight Testing in 2026 Offers Flexible Ordering, Clear Coverage Rules, and Actionable Reports

In 2026, GeneSight testing allows both clinicians and patients to choose between in-office and at-home DNA collection, with clear insurance coverage criteria and capped self-pay costs. Its color-coded ...
Nasdaq

GeneSight Psychotropic Test’s Combinatorial Approach Proves Better than Single-Gene Testing at Predicting Patient Outcomes and Medication Blood Levels

SALT LAKE CITY, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine, announced today the peer-reviewed journal Psychiatry Research ...
Nasdaq

Myriad Genetics (MYGN) Unveils GeneSight Test Enhancement

Myriad Genetics, Inc. MYGN recently announced improvements to the GeneSight Psychotropic test, a pharmacogenomic test for drugs used to treat mental illness. The GeneSight report will now contain ...
News Medical

GeneSight test better predicts antidepressant outcomes for patients with depression

The combinatorial, multi-gene GeneSight test has been found to better predict antidepressant treatment outcomes for patients with depression, and their use of health care resources, than any of the ...
Women's Health

“Making the Most of My Mental Health Medications With the GeneSight Test”

For years, Madeline Bohlman lit up the pageant stage, radiating confidence in dazzling gowns as crowds erupted in applause, leading her to win not one, but two titles. But behind her captivating smile ...
EurekAlert!

GeneSight Mental Health Monitor shows misunderstanding of depression and treatment

video: A new GeneSight Mental Health Monitor national survey finds 83 percent of those diagnosed with depression say life would be easier if others could understand what they're going through. Yet, ...